SILAC-based Proteomics Analysis on AML Cell Line with Transient Low-Dose Decitabine Treatment

碩士 === 國立臺灣大學 === 毒理學研究所 === 106 === Acute myeloid leukemia (AML) is an aggressive type of white blood cell cancer with most patients being beyond 60 years of age. These elderly patients are often present with various comorbidities that make them unsuitable for harsh conventional chemotherapy or cur...

Full description

Bibliographic Details
Main Authors: Giovanni Audrey Oswita, 胡斯萍
Other Authors: Hsing-Chen Tsai
Format: Others
Language:en_US
Published: 2018
Online Access:http://ndltd.ncl.edu.tw/handle/e3m5sa